98 related articles for article (PubMed ID: 15670308)
21. Impact of management on the prognosis of pure uterine papillary serous cancer - a Taiwanese Gynecologic Oncology Group (TGOG) study.
Huang CY; Tang YH; Chiang YC; Wang KL; Fu HC; Ke YM; Lau HY; Hsu KF; Wu CH; Cheng WF
Gynecol Oncol; 2014 May; 133(2):221-8. PubMed ID: 24556064
[TBL] [Abstract][Full Text] [Related]
22. [Epidemiological factors, treatment and prognosis of uterine sarcomas: 14 cases at the Cancer Institute of Dakar].
Dem A; Kasse AA; Diop M; Cisse B; Toure P
Dakar Med; 2000; 45(1):85-8. PubMed ID: 14666799
[TBL] [Abstract][Full Text] [Related]
23. The role of adjuvant radiation in uterine sarcomas.
Sampath S; Schultheiss TE; Ryu JK; Wong JY
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):728-34. PubMed ID: 19700247
[TBL] [Abstract][Full Text] [Related]
24. [Sarcoma of the endometrium. Epidemiology and prognostic factors. Apropos of a study of 22 cases].
Calais G; Frinot-Rousseau S; Body G; Fetissoff F; Le Floch O; Lansac J
J Gynecol Obstet Biol Reprod (Paris); 1989; 18(7):885-9. PubMed ID: 2614028
[TBL] [Abstract][Full Text] [Related]
25. Uterine Sarcomas: The Latest Approaches for These Rare but Potentially Deadly Tumors.
Chern JY; Boyd LR; Blank SV
Oncology (Williston Park); 2017 Mar; 31(3):229-36. PubMed ID: 28299760
[TBL] [Abstract][Full Text] [Related]
26. Uterine sarcomas: a review of the Edinburgh experience from 1974 to 1992.
Tinkler SD; Cowie VJ
Br J Radiol; 1993 Nov; 66(791):998-1001. PubMed ID: 8281393
[TBL] [Abstract][Full Text] [Related]
27. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
[TBL] [Abstract][Full Text] [Related]
28. Uterine endolymphatic stromal myosis: a collaborative study.
Piver MS; Rutledge FN; Copeland L; Webster K; Blumenson L; Suh O
Obstet Gynecol; 1984 Aug; 64(2):173-8. PubMed ID: 6738952
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of surgical treatment alone in patients with superficial soft tissue sarcoma regardless of size or grade.
Austin JL; Temple WJ; Puloski S; Schachar NS; Oddone Paolucci E; Kurien E; Sarkhosh K; Mack LA
J Surg Oncol; 2016 Jan; 113(1):108-13. PubMed ID: 26661586
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.
Odunsi K; Moneke V; Tammela J; Ghamande S; Seago P; Driscoll D; Marchetti D; Baker T; Lele S
Int J Gynecol Cancer; 2004; 14(4):659-64. PubMed ID: 15304162
[TBL] [Abstract][Full Text] [Related]
31. Treatment of uterine sarcoma at the University of Florence from 1980-2001.
Livi L; Paiar F; Meldolesi E; Simontacchi G; Amunni G; Barca R; Villanucci A; Scoccianti S; Piperno G; Biti G
Tumori; 2005; 91(2):139-43. PubMed ID: 15948541
[TBL] [Abstract][Full Text] [Related]
32. [Diagnosis and therapy of uterine sarcoma].
Viereck V; Huschmand Nia A; Pauer HU; Emons G; Krauss T
Zentralbl Gynakol; 2002 Nov; 124(11):506-10. PubMed ID: 12796843
[TBL] [Abstract][Full Text] [Related]
33. Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Sardi A; Sipok A; Baratti D; Deraco M; Sugarbaker P; Salti G; Yonemura Y; Sammartino P; Glehen O; Bakrin N; Díaz-Montes TP; Gushchin V
Eur J Surg Oncol; 2017 Nov; 43(11):2170-2177. PubMed ID: 28967566
[TBL] [Abstract][Full Text] [Related]
34. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.
Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL
Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850
[TBL] [Abstract][Full Text] [Related]
35. Retrospective study of management of uterine sarcomas at Oxford 1990-1998: role of adjuvant treatment.
Riddle PJ; Echeta CB; Manek S; Lavery BA; Charnock FM; Mackenzie I; Ganesan TS
Clin Oncol (R Coll Radiol); 2002 Feb; 14(1):54-61. PubMed ID: 11899904
[TBL] [Abstract][Full Text] [Related]
36. The management of patients with uterine sarcoma: a debated clinical challenge.
Gadducci A; Cosio S; Romanini A; Genazzani AR
Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
[TBL] [Abstract][Full Text] [Related]
37. Survival, patterns of spread and prognostic factors in uterine sarcoma: a study of 76 patients.
Moskovic E; MacSweeney E; Law M; Price A
Br J Radiol; 1993 Nov; 66(791):1009-15. PubMed ID: 8281375
[TBL] [Abstract][Full Text] [Related]
38. The role of surgery and treatment trends in uterine sarcoma.
Benoit L; Arnould L; Cheynel N; Goui S; Collin F; Fraisse J; Cuisenier J
Eur J Surg Oncol; 2005 May; 31(4):434-42. PubMed ID: 15837053
[TBL] [Abstract][Full Text] [Related]
39. Soft-tissue sarcomas of the head and neck: a retrospective analysis of the Alberta experience 1974 to 1999.
Huber GF; Matthews TW; Dort JC
Laryngoscope; 2006 May; 116(5):780-5. PubMed ID: 16652087
[TBL] [Abstract][Full Text] [Related]
40. Mucinous adenocarcinoma of the endometrium: case series and review of the literature.
Jalloul RJ; Elshaikh MA; Ali-Fehmi R; Haley MM; Yoon J; Mahan M; Munkarah AR
Int J Gynecol Cancer; 2012 Jun; 22(5):812-8. PubMed ID: 22569105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
